ASTRAZENECA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,898.00 GBX | +0.35% |
|
-1.26% | +12.25% |
| Sep. 18 | European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August | MT |
| Sep. 18 | AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment | MT |
EPS & Dividend: AstraZeneca PLC
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 2.8 | 2.8 | 2.87 | 2.9 | 2.9 | 3.098 | 3.264 | 3.405 |
| Rate of return | 2.78% | 2.8% | 2.44% | 2.15% | 2.15% | 1.96% | 2.07% | 2.16% |
| EPS 2 | 1.03 | 2.44 | 0.08 | 2.11 | 3.81 | 5.582 | 6.525 | 7.298 |
| Distribution rate | 272% | 115% | 3,588% | 137% | 76.1% | 55.5% | 50% | 46.7% |
| Reference price 2 | 100.75 | 99.99 | 117.51 | 135.16 | 135.02 | 157.92 | 157.92 | 157.92 |
| Nbr of stocks (in thousands) | 1,311,913 | 1,312,660 | 1,549,159 | 1,549,528 | 1,549,926 | 1,550,287 | - | - |
| Announcement Date | 2/14/20 | 2/11/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: AstraZeneca PLC
| 2024-08-07 | Interim Payment 0.776 GBP |
| 2024-02-21 | Final Payment 1.56 GBP |
| 2023-08-09 | Interim Payment 0.718 GBP |
| 2023-02-22 | Final Payment 1.628 GBP |
| 2022-08-10 | Interim Payment 0.764 GBP |
| 2022-02-23 | Final Payment 1.453 GBP |
| 2021-08-11 | Interim Payment 0.648 GBP |
| 2021-02-24 | Final Payment 1.374 GBP |
| 2020-08-12 | Interim Payment 0.696 GBP |
| 2020-02-26 | Final Payment 1.464 GBP |
| 2019-08-07 | Interim Payment 0.719 GBP |
| 2019-02-27 | Final Payment 1.468 GBP |
| 2018-08-08 | Interim Payment 0.684 GBP |
| 2018-02-14 | Final Payment 1.336 GBP |
| 2017-08-09 | Interim Payment 0.689 GBP |
| 2017-02-15 | Final Payment 1.502 GBP |
| 2016-08-10 | Interim Payment 0.687 GBP |
| 2016-02-17 | Final Payment 1.31 GBP |
| 2015-08-12 | Interim Payment 0.575 GBP |
| 2015-02-18 | Final Payment 1.25 GBP |
Upcoming events: AstraZeneca PLC
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +1.98% | +2.08% | 28.05x | 5.769 | 5.05x | ||
| +0.57% | +0.66% | 58.35x | 40.20 | 18.08x | ||
| +1.29% | +1.70% | 38.84x | 27.22 | 13.53x | ||
| +2.82% | +3.09% | 21.27x | 5.662 | 4.6x | ||
| +3.23% | +3.34% | 37.55x | 40.78 | 7.12x | ||
| +2.59% | +2.72% | 15.82x | 6.128 | 5.02x | ||
| +3.67% | +3.76% | 16.1x | 5.880 | 3.8x | ||
| +3.26% | +3.38% | 21.51x | 5.259 | 4.96x | ||
| +2.76% | +2.98% | 51.29x | 35.65 | 6.9x | ||
| +5.60% | +5.71% | 21.85x | 1.923 | 3.73x | ||
| Average | +2.78% | +2.94% | 31.06x | 17.45 | 7.28x | |
| Weighted average by Cap. | +2.23% | +2.41% | 35.54x | 22.01 | 9.55x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
